Abivax Stock Price, News & Analysis
Company Description
Abivax (OTC Link: AAVXF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $9.6B.
AAVXF stock has gained 1890.5% over the past year. Shares last traded at $115.65.
This page provides a comprehensive overview of AAVXF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Abivax (AAVXF) stock last traded at $115.65. Over the past 12 months, the stock has gained 1890.5%. At a market capitalization of $9.6B, AAVXF is classified as a mid-cap stock with approximately 63.3M shares outstanding.
Latest News
SEC Filings
Abivax has filed 5 recent SEC filings, including 2 Form 6-K, 1 Form 20-F, 1 Form SCHEDULE 13G/A, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on March 23, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all AAVXF SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Abivax (AAVXF) currently stands at 11.2 thousand shares, down 39.7% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 61.1%. This relatively low short interest suggests limited bearish sentiment. With 287.8 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Abivax (AAVXF) currently stands at 287.8 days, down 71.2% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has decreased 71.2% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
AAVXF Company Profile & Sector Positioning
Abivax (AAVXF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.